Figure 1
Figure 1. DNFB induces strong tissue necrosis in TNFR1+/+ mice. (A) DNFB-sensitized and -challenged TNFR1+/+ mice developed reduced ear swelling responses 24 hours after ear challenge compared with TNFR1−/− mice (n = 5-7). (B) TNCB-sensitized and -challenged TNFR1−/− mice developed reduced ear swelling responses 24 hours after ear challenge compared with TNFR1+/+ mice (n = 16-27). (C) Enhanced tissue necrosis in TNFR1+/+ mice after DNFB application. Hematoxylin and eosin–stained abdominal skin sections from TNCB-treated (top left) or DNFB-treated (top right) TNFR1+/+ and from TNCB-treated (bottom left) or DNFB-treated (bottom right) TNFR1−/− mice at day 5 after hapten application on the abdomen (n = 3-5).

DNFB induces strong tissue necrosis in TNFR1+/+ mice. (A) DNFB-sensitized and -challenged TNFR1+/+ mice developed reduced ear swelling responses 24 hours after ear challenge compared with TNFR1−/− mice (n = 5-7). (B) TNCB-sensitized and -challenged TNFR1−/− mice developed reduced ear swelling responses 24 hours after ear challenge compared with TNFR1+/+ mice (n = 16-27). (C) Enhanced tissue necrosis in TNFR1+/+ mice after DNFB application. Hematoxylin and eosin–stained abdominal skin sections from TNCB-treated (top left) or DNFB-treated (top right) TNFR1+/+ and from TNCB-treated (bottom left) or DNFB-treated (bottom right) TNFR1−/− mice at day 5 after hapten application on the abdomen (n = 3-5).

Close Modal

or Create an Account

Close Modal
Close Modal